Evidence map›Paper›PMID 35648748›Full record

ArticlePloS one2022

Determinants of the COVID-19 vaccine hesitancy spectrum.

Rachael Piltch-Loeb, Diana R Silver, Yeerae Kim, Hope Norris, Elizabeth McNeill, David M Abramson

Erratum issued 2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06290206 nacompletednot on this mapstarted 2024, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - BootCamp Translation

TypeinterventionalSponsorUniversity of UtahRan2024 to 2024Enrolled18ConditionsHPV Vaccination, Vaccine, Uptake, VaccinationArmsPREVENT - BCT
NCT06738355 nacompletednot on this mapstarted 2025, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Pilot Trial

TypeinterventionalSponsorUniversity of UtahRan2025 to 2025Enrolled335ConditionsHPV Vaccination, Uptake Vaccination, Series CompletionArmsPREVENT
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Findings from the 2025 AMCP Foundation Symposium: Health Optimization 2.0.Journal of managed care & specialty pharmacy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Perceptions of COVID-19 vaccine side effects by political affiliation.Journal of public health (Oxford, England) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rachael Piltch-LoebCenter for Public Health Disaster Science, School of Global Public Health, New York University, New York, New York, United States of America.ORCID 0000-0002-6813-1934
Diana R SilverDepartment of Public Health Policy and Management, School of Global Public Health, New York University, New York, New York, United States of America.
Yeerae KimCenter for Public Health Disaster Science, School of Global Public Health, New York University, New York, New York, United States of America.
Hope NorrisDepartment of Public Health Policy and Management, School of Global Public Health, New York University, New York, New York, United States of America.
Elizabeth McNeillDepartment of Public Health Policy and Management, School of Global Public Health, New York University, New York, New York, United States of America.
David M AbramsonCenter for Public Health Disaster Science, School of Global Public Health, New York University, New York, New York, United States of America.
New York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine hesitancy remains an issue in the United States. This study conducted an online survey [N = 3,013] using the Social Science Research Solution [SSRS] Opinion Panel web panelists, representative of U.S. adults age 18 and older who use the internet, with an oversample of rural-dwelling and minority populations between April 8 and April 22, 2021- as vaccine eligibility opened to the country. We examined the relationship between COVID-19 exposure and socio-demographics with vaccine intentions [eager-to-take, wait-and-see, undecided, refuse] among the unvaccinated using multinomial logistic regressions [ref: fully/partially vaccinated]. Results showed vaccine intentions varied by demographic characteristics and COVID-19 experience during the period that eligibility for the vaccine was extended to all adults. At the time of the survey approximately 40% of respondents were unvaccinated; 41% knew someone who had died of COVID-19, and 38% had experienced financial hardship as a result of the pandemic. The vaccinated were more likely to be highly educated, older adults, consistent with the United States initial eligibility criteria. Political affiliation and financial hardship experienced during the pandemic were the two most salient factors associated with being undecided or unwilling to take the vaccine.

Indexed as

COVID-19Urogenital AbnormalitiesVaccinesAdolescentAgedCOVID-19 VaccinesHumansUnited StatesVaccinationVaccination HesitancyCOVID-19 VaccinesVaccines

Identifiers

PMID35648748
PMCPMC9159626
OpenAlexW4281726376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.